List of Tables
Table 1. Global ERA Drugs Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global ERA Drugs Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global ERA Drugs Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global ERA Drugs Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global ERA Drugs Revenue by Region (2026-2031) & (US$ Million)
Table 6. Global ERA Drugs Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Units)
Table 7. Global ERA Drugs Sales by Region (2020-2025) & (K Units)
Table 8. Global ERA Drugs Sales by Region (2026-2031) & (K Units)
Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 10. Global ERA Drugs Sales by Manufacturers (2020-2025) & (K Units)
Table 11. Global ERA Drugs Sales Share by Manufacturers (2020-2025)
Table 12. Global ERA Drugs Revenue by Manufacturers (2020-2025) & (US$ Million)
Table 13. Global ERA Drugs Revenue Market Share by Manufacturers (2020-2025)
Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 15. Global ERA Drugs by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in ERA Drugs as of 2024)
Table 16. Global ERA Drugs Average Gross Margin (%) by Manufacturer (2020 VS 2024)
Table 17. Global ERA Drugs Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)
Table 18. Key Manufacturers ERA Drugs Manufacturing Base and Headquarters
Table 19. Global ERA Drugs Market Concentration Ratio (CR5 and HHI)
Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 22. Global ERA Drugs Sales by Type (2020-2025) & (K Units)
Table 23. Global ERA Drugs Sales by Type (2026-2031) & (K Units)
Table 24. Global ERA Drugs Revenue by Type (2020-2025) & (US$ Million)
Table 25. Global ERA Drugs Revenue by Type (2026-2031) & (US$ Million)
Table 26. Global ERA Drugs ASP by Type (2020-2031) & (US$/Unit)
Table 27. Technical Specifications by Key Product Type
Table 28. Global ERA Drugs Sales by Application (2020-2025) & (K Units)
Table 29. Global ERA Drugs Sales by Application (2026-2031) & (K Units)
Table 30. ERA Drugs High-Growth Sectors Demand CAGR (2024-2031)
Table 31. Global ERA Drugs Revenue by Application (2020-2025) & (US$ Million)
Table 32. Global ERA Drugs Revenue by Application (2026-2031) & (US$ Million)
Table 33. Global ERA Drugs ASP by Application (2020-2031) & (US$/Unit)
Table 34. Top Customers by Region
Table 35. Top Customers by Application
Table 36. North America ERA Drugs Growth Accelerators and Market Barriers
Table 37. North America ERA Drugs Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 38. North America ERA Drugs Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 39. Europe ERA Drugs Growth Accelerators and Market Barriers
Table 40. Europe ERA Drugs Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Europe ERA Drugs Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 42. Asia-Pacific ERA Drugs Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 43. Asia-Pacific ERA Drugs Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 44. Asia-Pacific ERA Drugs Growth Accelerators and Market Barriers
Table 45. Southeast Asia ERA Drugs Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Central and South America ERA Drugs Investment Opportunities and Key Challenges
Table 47. Central and South America ERA Drugs Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 48. Middle East and Africa ERA Drugs Investment Opportunities and Key Challenges
Table 49. Middle East and Africa ERA Drugs Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 50. Johnson & Johnson Corporation Information
Table 51. Johnson & Johnson Description and Major Businesses
Table 52. Johnson & Johnson Product Models, Descriptions and Specifications
Table 53. Johnson & Johnson Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 54. Johnson & Johnson Sales Value Proportion by Product in 2024
Table 55. Johnson & Johnson Sales Value Proportion by Application in 2024
Table 56. Johnson & Johnson Sales Value Proportion by Geographic Area in 2024
Table 57. Johnson & Johnson ERA Drugs SWOT Analysis
Table 58. Johnson & Johnson Recent Developments
Table 59. Zhengda Tianqing Corporation Information
Table 60. Zhengda Tianqing Description and Major Businesses
Table 61. Zhengda Tianqing Product Models, Descriptions and Specifications
Table 62. Zhengda Tianqing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 63. Zhengda Tianqing Sales Value Proportion by Product in 2024
Table 64. Zhengda Tianqing Sales Value Proportion by Application in 2024
Table 65. Zhengda Tianqing Sales Value Proportion by Geographic Area in 2024
Table 66. Zhengda Tianqing ERA Drugs SWOT Analysis
Table 67. Zhengda Tianqing Recent Developments
Table 68. Sinotherapeutics Corporation Information
Table 69. Sinotherapeutics Description and Major Businesses
Table 70. Sinotherapeutics Product Models, Descriptions and Specifications
Table 71. Sinotherapeutics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 72. Sinotherapeutics Sales Value Proportion by Product in 2024
Table 73. Sinotherapeutics Sales Value Proportion by Application in 2024
Table 74. Sinotherapeutics Sales Value Proportion by Geographic Area in 2024
Table 75. Sinotherapeutics ERA Drugs SWOT Analysis
Table 76. Sinotherapeutics Recent Developments
Table 77. Qilu Pharmaceutical Corporation Information
Table 78. Qilu Pharmaceutical Description and Major Businesses
Table 79. Qilu Pharmaceutical Product Models, Descriptions and Specifications
Table 80. Qilu Pharmaceutical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 81. Qilu Pharmaceutical Sales Value Proportion by Product in 2024
Table 82. Qilu Pharmaceutical Sales Value Proportion by Application in 2024
Table 83. Qilu Pharmaceutical Sales Value Proportion by Geographic Area in 2024
Table 84. Qilu Pharmaceutical ERA Drugs SWOT Analysis
Table 85. Qilu Pharmaceutical Recent Developments
Table 86. Hangzhou Zhongmei Huadong Pharmaceutical Corporation Information
Table 87. Hangzhou Zhongmei Huadong Pharmaceutical Description and Major Businesses
Table 88. Hangzhou Zhongmei Huadong Pharmaceutical Product Models, Descriptions and Specifications
Table 89. Hangzhou Zhongmei Huadong Pharmaceutical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 90. Hangzhou Zhongmei Huadong Pharmaceutical Sales Value Proportion by Product in 2024
Table 91. Hangzhou Zhongmei Huadong Pharmaceutical Sales Value Proportion by Application in 2024
Table 92. Hangzhou Zhongmei Huadong Pharmaceutical Sales Value Proportion by Geographic Area in 2024
Table 93. Hangzhou Zhongmei Huadong Pharmaceutical ERA Drugs SWOT Analysis
Table 94. Hangzhou Zhongmei Huadong Pharmaceutical Recent Developments
Table 95. Shanghai Xudong Haipu Pharmaceutical Corporation Information
Table 96. Shanghai Xudong Haipu Pharmaceutical Description and Major Businesses
Table 97. Shanghai Xudong Haipu Pharmaceutical Product Models, Descriptions and Specifications
Table 98. Shanghai Xudong Haipu Pharmaceutical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 99. Shanghai Xudong Haipu Pharmaceutical Recent Developments
Table 100. Shanghai Pharmaceutical Group Corporation Information
Table 101. Shanghai Pharmaceutical Group Description and Major Businesses
Table 102. Shanghai Pharmaceutical Group Product Models, Descriptions and Specifications
Table 103. Shanghai Pharmaceutical Group Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 104. Shanghai Pharmaceutical Group Recent Developments
Table 105. Jiangsu Yunyang Group Pharmaceutical Corporation Information
Table 106. Jiangsu Yunyang Group Pharmaceutical Description and Major Businesses
Table 107. Jiangsu Yunyang Group Pharmaceutical Product Models, Descriptions and Specifications
Table 108. Jiangsu Yunyang Group Pharmaceutical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 109. Jiangsu Yunyang Group Pharmaceutical Recent Developments
Table 110. Mylan Corporation Information
Table 111. Mylan Description and Major Businesses
Table 112. Mylan Product Models, Descriptions and Specifications
Table 113. Mylan Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 114. Mylan Recent Developments
Table 115. Teva Corporation Information
Table 116. Teva Description and Major Businesses
Table 117. Teva Product Models, Descriptions and Specifications
Table 118. Teva Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 119. Teva Recent Developments
Table 120. Dr. Reddy's Laboratories Corporation Information
Table 121. Dr. Reddy's Laboratories Description and Major Businesses
Table 122. Dr. Reddy's Laboratories Product Models, Descriptions and Specifications
Table 123. Dr. Reddy's Laboratories Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 124. Dr. Reddy's Laboratories Recent Developments
Table 125. Gilead Sciences Corporation Information
Table 126. Gilead Sciences Description and Major Businesses
Table 127. Gilead Sciences Product Models, Descriptions and Specifications
Table 128. Gilead Sciences Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 129. Gilead Sciences Recent Developments
Table 130. United Therapeutics Corporation Information
Table 131. United Therapeutics Description and Major Businesses
Table 132. United Therapeutics Product Models, Descriptions and Specifications
Table 133. United Therapeutics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 134. United Therapeutics Recent Developments
Table 135. Key Raw Materials Distribution
Table 136. Raw Materials Key Suppliers
Table 137. Critical Raw Material Supplier Concentration (2024) & Risk Index
Table 138. Milestones in Production Technology Evolution
Table 139. Distributors List
Table 140. Market Trends and Market Evolution
Table 141. Market Drivers and Opportunities
Table 142. Market Challenges, Risks, and Restraints
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
List of Figures
Figure 1. ERA Drugs Product Picture
Figure 2. Global ERA Drugs Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Bosentan Product Picture
Figure 4. Ambrisentan Product Picture
Figure 5. Macitentan Product Picture
Figure 6. Global ERA Drugs Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 7. Hospital
Figure 8. Clinic
Figure 9. Other
Figure 10. ERA Drugs Report Years Considered
Figure 11. Global ERA Drugs Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global ERA Drugs Revenue (2020-2031) & (US$ Million)
Figure 13. Global ERA Drugs Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 14. Global ERA Drugs Revenue Market Share by Region (2020-2031)
Figure 15. Global ERA Drugs Sales (2020-2031) & (K Units)
Figure 16. Global ERA Drugs Sales (CAGR) by Region (2020-2031) (K Units)
Figure 17. Global ERA Drugs Sales Market Share by Region (2020-2031)
Figure 18. Top 5 and Top 10 Manufacturers ERA Drugs Sales Volume Market Share in 2024
Figure 19. Global ERA Drugs Revenue Market Share Ranking (2024)
Figure 20. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 21. Bosentan Revenue Market Share by Manufacturer in 2024
Figure 22. Ambrisentan Revenue Market Share by Manufacturer in 2024
Figure 23. Macitentan Revenue Market Share by Manufacturer in 2024
Figure 24. Global ERA Drugs Sales Market Share by Type (2020-2031)
Figure 25. Global ERA Drugs Revenue Market Share by Type (2020-2031)
Figure 26. Global ERA Drugs Sales Market Share by Application (2020-2031)
Figure 27. Global ERA Drugs Revenue Market Share by Application (2020-2031)
Figure 28. North America ERA Drugs Sales YoY (2020-2031) & (K Units)
Figure 29. North America ERA Drugs Revenue YoY (2020-2031) & (US$ Million)
Figure 30. North America Top 5 Manufacturers ERA Drugs Sales Revenue (US$ Million) in 2024
Figure 31. North America ERA Drugs Sales Volume (K Units) by Type (2020- 2031)
Figure 32. North America ERA Drugs Sales Revenue (US$ Million) by Type (2020 - 2031)
Figure 33. North America ERA Drugs Sales Volume (K Units) by Application (2020-2031)
Figure 34. North America ERA Drugs Sales Revenue (US$ Million) by Application (2020-2031)
Figure 35. US ERA Drugs Revenue (2020-2031) & (US$ Million)
Figure 36. Canada ERA Drugs Revenue (2020-2031) & (US$ Million)
Figure 37. Mexico ERA Drugs Revenue (2020-2031) & (US$ Million)
Figure 38. Europe ERA Drugs Sales YoY (2020-2031) & (K Units)
Figure 39. Europe ERA Drugs Revenue YoY (2020-2031) & (US$ Million)
Figure 40. Europe Top 5 Manufacturers ERA Drugs Sales Revenue (US$ Million) in 2024
Figure 41. Europe ERA Drugs Sales Volume (K Units) by Type (2020-2031)
Figure 42. Europe ERA Drugs Sales Revenue (US$ Million) by Type (2020-2031)
Figure 43. Europe ERA Drugs Sales Volume (K Units) by Application (2020-2031)
Figure 44. Europe ERA Drugs Sales Revenue (US$ Million) by Application (2020-2031)
Figure 45. Germany ERA Drugs Revenue (2020-2031) & (US$ Million)
Figure 46. France ERA Drugs Revenue (2020-2031) & (US$ Million)
Figure 47. U.K. ERA Drugs Revenue (2020-2031) & (US$ Million)
Figure 48. Italy ERA Drugs Revenue (2020-2031) & (US$ Million)
Figure 49. Russia ERA Drugs Revenue (2020-2031) & (US$ Million)
Figure 50. Asia-Pacific ERA Drugs Sales YoY (2020-2031) & (K Units)
Figure 51. Asia-Pacific ERA Drugs Revenue YoY (2020-2031) & (US$ Million)
Figure 52. Asia-Pacific Top 8 Manufacturers ERA Drugs Sales Revenue (US$ Million) in 2024
Figure 53. Asia-Pacific ERA Drugs Sales Volume (K Units) by Type (2020- 2031)
Figure 54. Asia-Pacific ERA Drugs Sales Revenue (US$ Million) by Type (2020- 2031)
Figure 55. Asia-Pacific ERA Drugs Sales Volume (K Units) by Application (2020-2031)
Figure 56. Asia-Pacific ERA Drugs Sales Revenue (US$ Million) by Application (2020-2031)
Figure 57. Indonesia ERA Drugs Revenue (2020-2031) & (US$ Million)
Figure 58. Japan ERA Drugs Revenue (2020-2031) & (US$ Million)
Figure 59. South Korea ERA Drugs Revenue (2020-2031) & (US$ Million)
Figure 60. China Taiwan ERA Drugs Revenue (2020-2031) & (US$ Million)
Figure 61. India ERA Drugs Revenue (2020-2031) & (US$ Million)
Figure 62. Central and South America ERA Drugs Sales YoY (2020-2031) & (K Units)
Figure 63. Central and South America ERA Drugs Revenue YoY (2020-2031) & (US$ Million)
Figure 64. Central and South America Top 5 Manufacturers ERA Drugs Sales Revenue (US$ Million) in 2024
Figure 65. Central and South America ERA Drugs Sales Volume (K Units) by Type (2021-2031)
Figure 66. Central and South America ERA Drugs Sales Revenue (US$ Million) by Type (2020-2031)
Figure 67. Central and South America ERA Drugs Sales Volume (K Units) by Application (2020-2031)
Figure 68. Central and South America ERA Drugs Sales Revenue (US$ Million) by Application (2020-2031)
Figure 69. Brazil ERA Drugs Revenue (2020-2025) & (US$ Million)
Figure 70. Argentina ERA Drugs Revenue (2020-2025) & (US$ Million)
Figure 71. Middle East, and Africa ERA Drugs Sales YoY (2020-2031) & (K Units)
Figure 72. Middle East and Africa ERA Drugs Revenue YoY (2020-2031) & (US$ Million)
Figure 73. Middle East and Africa Top 5 Manufacturers ERA Drugs Sales Revenue (US$ Million) in 2024
Figure 74. Middle East and Africa ERA Drugs Sales Volume (K Units) by Type (2021-2031)
Figure 75. South America ERA Drugs Sales Revenue (US$ Million) by Type (2020-2031)
Figure 76. Middle East and Africa ERA Drugs Sales Volume (K Units) by Application (2020-2031)
Figure 77. Middle East and Africa ERA Drugs Sales Revenue (US$ Million) by Application (2020-2031)
Figure 78. GCC Countries ERA Drugs Revenue (2020-2025) & (US$ Million)
Figure 79. Turkey ERA Drugs Revenue (2020-2025) & (US$ Million)
Figure 80. Egypt ERA Drugs Revenue (2020-2025) & (US$ Million)
Figure 81. South Africa ERA Drugs Revenue (2020-2025) & (US$ Million)
Figure 82. ERA Drugs Industry Chain Mapping
Figure 83. Regional ERA Drugs Manufacturing Base Distribution (%)
Figure 84. Global ERA Drugs Production Market Share by Region (2020-2031)
Figure 85. ERA Drugs Production Process
Figure 86. Regional ERA Drugs Production Cost Structure
Figure 87. Channels of Distribution (Direct Vs Distribution)
Figure 88. Bottom-up and Top-down Approaches for This Report
Figure 89. Data Triangulation
Figure 90. Key Executives Interviewed
